The Beijing company said it selected the United Arab Emirates because of its ethnic diversity, which will enable it to determine the feasibility of taking its program global. It claims that its study is the first Phase III inactivated vaccine trial, but another Chinese firm has also launched one in Brazil.
Veteran international healthcare entrepreneur Semih Sen will also oversee Cleveland Clinic Innovations, the commercialization arm of the organization, which is focused on bringing research IP into the market.
Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.
The University of Pennsylvania Health System is the latest U.S. provider to seek a foothold in the United Arab Emirates.